statistiche ricercatore

Continente	#
AS - Asia	181
NA - Nord America	134
EU - Europa	34
SA - Sud America	14
Continente sconosciuto - Info sul continente non disponibili	14
AF - Africa	2
OC - Oceania	1
Totale	380

Nome	#
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma	40
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy	38
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy	37
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma	37
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma	35
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors	33
BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes	30
Use of artificial intelligence chatbots in clinical management of immune-related adverse events	30
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge	28
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma	28
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies	23
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data	16
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.	5
Totale	380

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2025/2026	360	0	0	0	0	86	52	56	68	47	27	11	13
2026/2027	20	20	0	0	0	0	0	0	0	0	0	0	0
Totale													380